BAYRY enters into a collaboration and license agreement with Cytokinetics for the exclusive development and commercialization ...

An independent researcher said the results should spark a re-evaluation of some medicines, but do not necessarily mean ...

Capricor Therapeutics (NASDAQ:CAPR) announced Wednesday that the European Medicines Agency has issued Orphan Drug and ...

Nice said it was ‘extremely disappointed’ it will be unable to recommend trastuzumab deruxtecan, sold under the brand name Enhertu.